BAVARIAN NORDIC - 1000% pumpI expect a very strong increase in this company’s stock due to the impending monkeypox problem. Therefore, it is a very good idea to buy it. Wishing everyone health and prosperity.
BVNRY trade ideas
Bavarian Nordic : new mpox problemwe seem to be on the edge of a new pandemic with a deadlier mpox strain than 2022 (3-5 % mortality rate). BAVA is one of the vaccine producers and most likely got an Invitation for EUL from WHO (see www.who.int) . BAVA is one of the 2 Producers of vaccines (JYNNEOS from BAVA and ACCAM2000 from Emergent Bio)
critical point herelet us se what happens here. The company has finansed it's pipelines and have also good thing in pipeline beside the selling of its vaccines.
Monkey Pox vaxBeen tracking cdc data on monkey pox from 1st week of may this year. Cases have gone from 7 to 22k+ today. Their can be much speculation as to why or what this actually will be, but that would be another website. Bavarian Nordic has already received the green light from US and EU to mass produce these vaccines in a Denmark facility. I expect cases to explode, and that we will find out that just about anyone can get this..So these guys are the market. Weekly measured move from the wedge is 160$ area, The 1.618 of the top to low of the formation is right around the same area. I think this gets tagged by year end..Not going to move in a straight line here, absolutely could pull back. However,SanFran, and NYC have already declared a state of emergency as of Yesterday....Always do what you think is best, this is in no way financial advice. GL
BAVA: Monkey Pox Pharma Inverse on Bullish NewsThis accompany has just opened a contract with US and EU markets for 800k dose for Monkey POX in the US. Inverse printing. When Moderna received a contract for COIVD is 4x'd. I cant see why this wouldn't at least pump another 40% to the 1.618
Monkeypox Vaccine about to break year downtrend?Now in 30 countries and just found in India UK ordering directly from the company and earnings at the end of August
Pandemic 2.0This is not financial advice and any information that you take and act upon is at your sole discretion.
History doesn't repeat itself, but if often rhymes. If the saying holds true then Bavarian Nordic (BAVA) stands to see a great increase in it's stock price.
Listen to the video for a rundown of the fundamental analysis.
This is not financial advice and any information that you take and act upon is at your sole discretion.
$BVNRY PTs 300-400 and higher Bavarian Nordic is the only company with an FDA approved Monkey Pox Vaccine
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
BAVA MonkeyPox VaccineHere we go again...?
"The spread of monkeypox boosted the shares of Bavarian Nordic A/S, which says it’s the only company to make a vaccine approved for the viral infection.
The Danish company gained as much as 26% in Copenhagen trading on Thursday after saying it had secured a contract to supply its smallpox shot -- which is also cleared against monkeypox -- to an undisclosed European country.
Monkeypox, a virus that is endemic in some forested parts of central and west Africa, has been found in a handful of cases in the UK, Spain and Portugal in recent days and in one person in the US. The World Health Organization said Wednesday it was monitoring a situation that 'is evolving rapidly.' "
www.bloomberg.com
Failed to break previous topBreakouts start a long period of retracement.
5 days breakout, leads to 148 days down periode.
21 days breakout leads to 59 days down periode (Currently ongoing).
Failed to break last top and got rejected.
BAVA: a great entrance pointBAVA is moving up in a channel looking at the chart back to april 2020. At the moment it is moving downwards inside this channel, and I think it will continue down below 280 Dkr. But to do so, it needs to break through and downwards from the wedge it is at presently. If it continues below 280 Dkr, it could mean a lot of upside, when it goes the other way towards the upper side of the channel.
Disclaimer: I hope I can inspire and entertain, but I am not a financial advisor. Please do your own research.
Possible short position in BAVABAVA has since March been in a uptrend moving up and down in a tunnel. Inside this tunnel, there is now a tunnel going down. If it follows this trend possible entry could be 317 and target at 288, for a 1-2 risk/reward. Stoploss at 328,8. It will proberbly go a little further down, before it goes back up again, should it follow the general uptrend.
BAVA - Strong Buy SetupBAVA - Strong Buy Setup
- Hammer in PB&J Sweet Spot (SMA 10 / EMA 30)
- Bollinger Band Lower
- DeMark Perfected Buy Setup
- Test of Falling Window Low
- Pivots P Monthly & 3 Month support
Ultimate Target: Top of Falling Window
SL: 250
T1: 317
T2: 340
T3: 400
BAVA - LongFundamental and Technical Analysis show this as a very strong buy candidate. I can see this hitting 930.00 within 8 Weeks.
Learning how to do TAHi,
Follow me along while I'm trying to learn TA.
This is for my own learning purposes, as I'm trying to learn TA.
x
LS
Bavarian nordic - KonsolideringszoneBavarian nordic har sat sig i en konsolideringszone. Den er afvist 2 gange i kurs 225 og har langsigtet sidste støtte i 176. Jeg forventer den vil ligge indenfor disse niveauer, indtil kommende regnskab eller nyheder. Herefter vil den bryde kurs 225.
BAVA Bullished 2nd attempt BAVA Bullished 2nd attempt,
Remember to follow volume and news about Bava.
